Arsenal Biosciences
Phase 1Arsenal Biosciences, Inc. is a clinical stage, programmable cell therapy company focused on solid tumor cell therapies to defeat cancer.
Founded
2019
Focus
Cell & Gene Therapy
About
Arsenal Biosciences, Inc. is a clinical stage, programmable cell therapy company focused on solid tumor cell therapies to defeat cancer.
Funding History
2Total raised: $305M
Series A$220MSoftBank Vision Fund 2Sep 15, 2022
Seed$85MWestlake Village BioPartnersJun 15, 2020
Company Info
TypePrivate
Founded2019
LocationSouth San Francisco, United States
StagePhase 1
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile